Uncertainties page: Should more patients with acute ischaemic stroke receive thrombolytic treatment?

BMJ (Online)

Volumn 339, Issue 7732, 2009, Pages 1251-1253

  Wardlaw, Joanna M ^a   Sandercock, Peter A G ^a   Murray, Veronica ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGE DISTRIBUTION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; TREATMENT DURATION; TREATMENT OUTCOME; UNCERTAINTY; ARTICLE; BRAIN ISCHEMIA; EVIDENCE BASED MEDICINE; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; STROKE; UTILIZATION REVIEW;

BIOMEDICAL RESEARCH; BRAIN ISCHEMIA; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 71749115105     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4584     Document Type: Short Survey

References (15)

1. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-1587[Abstract/Free Full Text]
2. Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003;(3):CD000213.
3. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774[CrossRef][Web of Science][Medline]
4. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025[Abstract/Free Full Text]
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251[CrossRef][Web of Science][Medline] (Pubitemid 28470336)
6. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, az-Manera J, Aleu A, et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;64:719-720 [Abstract/Free Full Text]
7. Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, et al. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology 2005;64:2115-2120 [Abstract/Free Full Text] (Pubitemid 40881004)
8. Kapral MK, Laupacis A, Phillips SJ, Silver FL, Hill MD, Fang J, et al. Stroke care delivery in institutions participating in the registry of the Canadian Stroke Network. Stroke 2004;35:1756-1762 [Abstract/Free Full Text] (Pubitemid 38823660)
9. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106-1113[Abstract/Free Full Text] (Pubitemid 36547496)
10. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet 2007;369:275-282[CrossRef][Medline] (Pubitemid 46138121)
11. Leys D, Ringelstein EB, Kaste M, Hacke W. Facilities available in European hospitals treating stroke patients. Stroke 2007;38:2985-2991[Abstract/ Free Full Text] (Pubitemid 350035694)
12. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009;(4):CD000213.
13. European Stroke Organization (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507. [CrossRef][Web of Science][Medline]
14. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329[Abstract/Free Full Text]
15. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, et al. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. 2008. www.trialsjournal.com/content/9/1/37.